16 statistics on ASC valuation multiples

When purchasing a minority interest in a multispecialty facility, 50 percent of companies see prevailing valuation multiples of 4 times to 4.9 times EBITDA, according to HealthCare Appraisers’ 2018 ASC Valuation Survey.

Advertisement

Data was collected from 15 respondents representing 700-plus U.S. surgery centers.

Here are 16 statistics on the valuation multiples most typically observed for various interests in predominantly in-network centers:

Minority interest, single-specialty
1. 2 to 2.9 times: 8 percent
2. 3 to 3.4 times: 23 percent
3. 3.5 to 3.9 times: 15 percent
4. 4 to 4.9 times: 38 percent
5. 5 to 5.9 times: 15 percent

Controlling interest, single-specialty
6. 5 to 5.9 times: 23 percent
7. 6 to 6.9 times: 38 percent
8. 7 to 7.9 times: 38 percent

Minority interest, multispecialty
9. 3 to 3.4 times: 14 percent
10. 3.5 to 3.9 times: 21 percent
11. 4 to 4.9 times: 50 percent
12. 5 to 5.9 times: 7 percent
13. 6 to 6.9 times: 7 percent

Controlling interest multispecialty
14. 6 to 6.9 times: 29 percent
15. 7 to 7.9 times: 64 percent
16. 8+: 7 percent

More articles on benchmarking:
5 main drivers of healthcare acquisitions
Oversights & challenges in healthcare acquisitions — 11 statistics
79% of firms will pursue alliances or JVs in the near future — 8 statistics

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.